EN DE
Watch Kromek Group PLC for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Kromek Group PLC (KMK) fair value: what the stock is really worth

As of Nov 9, 2026: fair value (intrinsic value) of Kromek Group PLC stock £0.05, price £0.05, that is 4.1% below the price, quality 46 out of 100. Rating: fairly valued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Technology GB · ISIN GB00BD7V5D43

KG Kromek Group PLC logo Thin data Nov 9, 2026

Kromek Group PLC

KMK · LSE
Fairly valued, weak quality

The stock costs about what our calculation considers fair.

Healthy Growth (revenue 5y +21.2 %/yr in GBP)
Low debt
Generates free cash flow
Fair value £0.0523 · Fairly valued
Quality 46/100
Thin margins · 2.7% net margin (TTM)
Mixed vs. peers (6/12)
Revenue last quarter 47% below a year ago.
Narrow moat 28/100 · thin data
Thin data
Watch Kromek Group PLC for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

£0.1915 £0.0325 Fair Value £0.0523 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.

How to read this chart

60‑month range £0.0325 – £0.1915 · fair‑value band £0.0413 – £0.0633 · the £0.0545 price screens above the £0.0523 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.

Follow Kromek Group in your weekly email

Every Wednesday you see whether Kromek Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets.

Show moreShow less

It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection.

The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems.

In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples.

Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities.

It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.

Stock analysis

Kromek Group PLC (KMK) currently trades at £0.0545, while our model-based Fair Value estimate is £0.0523, so the stock looks roughly fairly valued today (gap 4.3%).

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of £0.0850 per share, and 13 of the 24 models we run sit above the £0.0545 price.

Bear case: the Asset-Based group reads lowest at £0.0200, and 11 of the 24 models stay below the price. Data coverage for this calculation is low.

Scenario range: £0.0413 (bear) to £0.0633 (bull), the price of £0.0545 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 46/100 (below-average quality), in the Technology sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Kromek Group PLC reported revenue of £27.1M in FY2026 versus £12.1M in FY2022, a compound +22.5%/yr. Reported net income was £733K in FY2026.

Key figures

Market cap £35.2M Micro · P/S ratio 1.35 · Net margin 2.7% · Return on equity 1.4% · Return on assets (EBIT) −1.7% (5-year average) · Operating margin −2.4% · Revenue (TTM) £27.1M · Revenue growth (YoY) −47.0%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 57% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Technology peers we cover trades at −45% fair-value upside, at −4%, KMK screens cheaper than that median.

Fair Value models

Bear £0.0413 Fair Value £0.0523 Bull £0.0633
Price £0.0545 · Downside -4.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF £0.0500 £0.0900 £0.1600 77
Growth DCF £0.0500 £0.0900 £0.1400 77
Owner Earnings £0.0400 £0.0800 £0.1300 74
All 24 models by family
DCF Models
FCF DCF £0.0500 £0.0900 £0.1600 77
Owner Earnings £0.0400 £0.0800 £0.1300 74
5Y Revenue Exit £0.0500 £0.0800 £0.1300 71
5Y EBITDA Exit £0.1100 £0.2100 £0.3500 73
5Y P/E Exit £0.0400 £0.0600 £0.0800 71
10Y Revenue Exit £0.0500 £0.0800 £0.1300 65
10Y EBITDA Exit £0.0900 £0.1700 £0.3100 65
10Y P/E Exit £0.0400 £0.0600 £0.0900 63
Earnings-Based
Graham-Dodd £0.0100 £0.0400 £0.0600 63
Lynch FV £0.0100 £0.0200 £0.0200 61
PEG = 1.0 £0.0100 £0.0200 £0.0200 57
EPV £0.0200 £0.0300 £0.0300 74
Multiples
P/E Multiple £0.0200 £0.0300 £0.0400 62
P/S Multiple £0.0100 £0.0200 £0.0200 58
P/B Multiple £0.1300 £0.1700 £0.2100 55
EV/EBIT £0.0700 £0.1000 £0.1300 65
EV/EBITDA £0.1400 £0.1800 £0.2300 67
EV/Revenue £0.0300 £0.0500 £0.0700 52
Asset-Based
NCAV (Graham) £0.0100 £0.0200 £0.0200 55
Growth DCF
Growth DCF £0.0500 £0.0900 £0.1400 77
Rev-Margin DCF £0.0500 £0.0800 £0.1300 71
Economic Profit
Residual Income £0.0500 £0.0500 £0.0500 71
ROIC Compounder £0.0200 £0.0300 £0.0300 72
Growth Earnings
Growth-Adj P/E £0.0200 £0.0300 £0.0400 67

Open the full fair value analysis →

Quality Score breakdown

Overall quality 46/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 24
How much profit the company makes from its sales and capital
Quality Growth 29
Are margins and returns getting better?
Cashflow 71
Do the profits arrive as real cash?
Financial strength 49
Debt, balance sheet and risk of trouble
Investment 79
Does it invest with discipline instead of growing at any price?
Low Volatility 16
How calm the share price moves, does not count
Price momentum 5
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 2
Distance to the 52-week high, does not count
New shares 38
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.2%
Start year 2021 (pandemic). Over 10 years: +12.5% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+19.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−56.4% (2021) → 10.7% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: no profitable base year
not computed

Growth Forecast

Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+6.2%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (UK: IMF forecast 2.3% a year to 2030, 3.3% from 2016 to 2025) that is about +3.8% a year for the price.

Watch KMK, get fair value alerts →

Compare Kromek Group PLC with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Scientific & Technical Instruments · 160 stocks

Beats the industry median on 6/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 46 · Below median
Fair Value upside −4.0% · Above median
Profitability
Return on equity (12 months) 1.4% · Below median
Return on assets 1.0% · Below median
Net margin (12 months) 2.7% · Below median
Operating margin (12 months) −2.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −47.0% · Bottom 25%
Balance sheet
Debt / equity 0.00× · Below median

Valuation Multiplesvs Scientific & Technical Instruments median · lower = cheaper

P/B 0.65× · Cheapest 25%
P/S (12 months) 1.30× · Cheapest 25%
Price / free cash flow (fiscal year) 13.2× · Cheapest 25%
EV/EBITDA 7.4× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)28 · sector 0
FUTURE (revenue growth)0 · sector 47
PAST (return on equity)6 · sector 24
HEALTH (low debt)100 · sector 99
DIVIDEND (yield)0 · sector 20

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Scientific & Technical Instruments stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Garmin Ltd GRMN $285.57 $314.13 +10% vs KMK
Teledyne Technologies Incorporated TDY $618.60 $680.46 +10% vs KMK
MKS Inc MKSI $192.27 $199.16 +4% vs KMK
Cognex Corporation CGNX $47.78 $38.10 −20% vs KMK
Fortive Corporation FTV $65.37 $35.67 −45% vs KMK
Trimble Inc TRMB $54.11 $29.48 −46% vs KMK
Chroma ATE Inc 2360 1,250 TWD 607.12 TWD −51% vs KMK
Coherent Corp COHR $192.81 $92.93 −52% vs KMK
Keysight Technologies, Inc KEYS $272.13 $117.27 −57% vs KMK
AVIC Chengdu Aircraft Company 302132 ¥69.73 ¥12.60 −82% vs KMK

Explore undervalued stocks

More undervalued Technology stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Kromek Group PLC: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Kromek Group PLC Fair Value". https://www.fairvalue-calculator.com/stock/KMK

Frequently asked questions

Is Kromek Group PLC (KMK) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of £0.0523 versus a price of £0.0545, about 4% lower (fairly valued).
What is the fair value of KMK?
Our model-based fair value for Kromek Group PLC is £0.0523 (as of Nov 9, 2026), built from audited fundamentals. The current price: £0.0545.
What is the quality score of KMK?
Kromek Group PLC has a Quality Score of 46/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kromek Group PLC (KMK)?
Our model-based price target is the fair value of £0.0523 (as of Nov 9, 2026) from 24 valuation models. Cautious scenario £0.0413, optimistic scenario £0.0633. It is a calculation from audited fundamentals, not an analyst target.
What is the Kromek Group PLC stock forecast for 2026?
Our models put fair value at £0.0523, about 4% lower versus a price of £0.0545 (fairly valued). Cautious scenario £0.0413, optimistic scenario £0.0633. The calculation is refreshed regularly with new filings.
What is the revenue of Kromek Group PLC (KMK)?
Kromek Group PLC reported trailing-twelve-month revenue of about £27.1M (latest available figure, as of Nov 9, 2026).
What growth is priced into Kromek Group PLC (KMK)?
For today's price to be fair in a discounted-cash-flow model, Kromek Group PLC would have to grow free cash flow by +6.2 % per year for five years (discount rate 11.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +21.2 % per year. As of Nov 9, 2026.
What discount rate (WACC) does the fair value of KMK use?
Our models discount Kromek Group PLC at 11.3 %: a base by market capitalisation (nano), damped by beta 1.39, country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kromek Group PLC that is +6.2 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (11.3 %) and the same formula as our fair value.
How much growth has Kromek Group PLC (KMK) delivered so far?
Over the past 5 years revenue at Kromek Group PLC grew +21.2 % a year. The price currently implies free-cash-flow growth of +6.2 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kromek Group PLC (KMK) growing?
The median revenue growth in the sector is +11.5 % a year. That is the yardstick for the growth priced into Kromek Group PLC (+6.2 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kromek Group PLC (KMK)?
The free-cash-flow yield on the price is 7.58 %: that much free cash flow Kromek Group PLC produces per unit of market value. When it exceeds the discount rate of our models (11.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kromek Group PLC (KMK)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kromek Group PLC it is £0.0523 per share (as of Nov 9, 2026), against a price of £0.0545. It is the blended result of 24 valuation models in 7 families (DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Kromek Group PLC stock overvalued or undervalued in 2026?
As of Nov 9, 2026, KMK trades above its calculated fair value: price £0.0545, fair value £0.0523, a gap of about −4% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KMK?
No. The price is what the market pays today (£0.0545); the fair value is what the company's own numbers justify (£0.0523). For Kromek Group PLC the two are £0.0023 per share apart. That gap is exactly why we show both numbers side by side.
How much is Kromek Group PLC worth?
The market values Kromek Group PLC at about £35.2M (market capitalisation, as of Nov 9, 2026). Per share that is £0.0545; our models calculate a fair value of £0.0523 per share.
What do the bullish and bearish scenarios say about KMK?
Our models span a range for Kromek Group PLC: cautious scenario £0.0413, base £0.0523, optimistic £0.0633 per share (as of Nov 9, 2026, price £0.0545). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Kromek Group PLC (KMK)?
Balance-sheet figures for Kromek Group PLC (as of Nov 9, 2026): return on equity 1.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 46/100, which measures business quality independently of the share price.
How far is KMK from its 52-week high?
Kromek Group PLC trades at £0.0545, about 57% below its 52-week high of £0.1255 and 1% above the low of £0.0540 (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of £0.0523 is for.
Which stocks are comparable to Kromek Group PLC?
From the same area (Technology) we also value Keysight Technologies, Inc, Garmin Ltd, Coherent Corp, Teledyne Technologies Incorporated, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kromek Group PLC stock attractive at the current price?
The data as of Nov 9, 2026: price £0.0545, calculated fair value £0.0523 (−4%), Quality Score 46/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KMK calculated?
We run Kromek Group PLC through 24 models from 7 families: DCF Models, Earnings-Based, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of £0.0523 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Kromek Group PLC itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kromek Group PLC (KMK)?
The closing price on Nov 9, 2026 was £0.0545. Our model-based fair value is £0.0523, about 4% lower (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kromek Group PLC right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Kromek Group PLC

How large is the market capitalisation of Kromek Group PLC (KMK)?
The market capitalisation of Kromek Group PLC is £35.2M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kromek Group PLC (KMK)?
The price-to-sales ratio of Kromek Group PLC is 1.35 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Kromek Group PLC (KMK)?
The net margin of Kromek Group PLC is 2.7% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kromek Group PLC (KMK)?
The return on equity (ROE) of Kromek Group PLC is 1.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kromek Group PLC (KMK)?
On an EBIT basis the return on assets of Kromek Group PLC is −1.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kromek Group PLC (KMK)?
The operating margin of Kromek Group PLC is −2.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kromek Group PLC (KMK)?
Revenue at Kromek Group PLC is growing −47.0% versus a year earlier (3y avg +16.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net debt does Kromek Group PLC (KMK) carry?
The net debt of Kromek Group PLC is £5.2M (fiscal year 2026, ≈ 1.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Kromek Group PLC in the live analysis

One click puts Kromek Group PLC on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.